WVSHP Logo Contact Information
News & Events

News from WVSHP

POCT Certificate Program

The University of Charleston School of Pharmacy will host a pharmacist training session on May 11th from 1-5 PM.  The program will provide the “Community Pharmacy-Based Point-of-Care Testing (POCT) Certificate Program” through the NACDS organization.
Specifics from NACDS include:
-Practical, hands-on training in point-of-care testing in four (4) disease states
-20 credit hours of ACPE-accredited continuing education
-Unique dual home study and in-person structure
-Access to and training on the interactive, web-based education platform
The cost will be:
    $400 for pharmacists
    $300 for UC alumni and preceptors
    $250 for any current UCSOP students
Contact Gannett Monk with any questions at gannettmonk@ucwv.edu, or to request the UC alumni/preceptor/student discount code.
To sign up, go to:  http://www.ucwv.edu/POCT/ 


ASHP and ACPE revised guidelines ASHP and the Accreditation Council for Pharmacy Education (ACPE) just released revisions to the Accreditation Standards for Pharmacy Technician Educat (Click for more...)

News from elsewhere...
‘Make use of community pharmacists’, NICE urges 1/22/2020 6:58:30 AM NICE is urging patients to ask their pharmacist advice about smoking, alcohol or maintaining a healthy weight. (Click for more...) Sunosi approved in Europe for EDS in narcolepsy, sleep apnoea 1/22/2020 6:52:46 AM The European Commission has accepted the drug to improve wakefulness and reduce excessive daytime sleepiness in the disorders. (Click for more...) PhoreMost enlists Otsuka in multi-project drug discovery collab 1/22/2020 5:52:05 AM The partnership will have an initial focus on gene therapy applications of identified targets. (Click for more...) NICE rejects Janssen’s Stelara on cost efficiency grounds 1/22/2020 5:12:11 AM The annual treatment costs are £14,482 in the induction year, and £9,304 per year for maintenance treatment. (Click for more...) Darzalex EU nod marks first newly diagnosed MM treatment in six years 1/22/2020 4:49:31 AM The approval was based on results from part one of the Phase III CASSIOPEIA study. (Click for more...) Fight for Sight to fund macular degeneration research 1/21/2020 3:05:03 AM As it stands, damage to the macula can’t be reversed, making it the most common cause of permanent and severe sight loss in the UK. (Click for more...) EU clears Roche’s Polivy for certain lymphomas 1/21/2020 2:52:24 AM The drug has been approved in combination with bendamustine and MabThera. (Click for more...) New scan could see active breast tumour regions in ‘real-time’ 1/21/2020 2:38:29 AM Breast cancer is the most common type of cancer in the UK, with around 55,000 new cases each year. (Click for more...) EMA licenses Mayzent for MS 1/21/2020 2:35:18 AM Novartis also expects NICE and SMC decisions in the first half of 2020. (Click for more...) ‘Weak antibiotic pipeline’ poses threat to AMR fight 1/20/2020 6:00:50 AM Of the 60 products in development, very few seem to show benefit over existing treatments. (Click for more...) HIV transmissions fall by 71% 1/20/2020 5:28:57 AM The UK is "well on its way towards our ambition of zero HIV transmissions by 2030." (Click for more...) Heart failure market could surpass ‘$22bn by 2028’ 1/20/2020 5:25:41 AM Due to the aging global population, recent years have seen an increased prevalence of chronic HF. (Click for more...) INTCR 2020 closing for entry midnight on Thursday 1/20/2020 4:05:12 AM The 2020 PharmaTimes International Clinical Researcher of the Year will be closing for entry at midnight this Thursday the 23rd of January. (Click for more...) Ibrance given NICE green light in breast cancer 1/17/2020 6:46:33 AM The recommendation is based on data from the Phase III clinical trial, PALOMA-3, in which Ibrance delayed disease progression by 6.6 months. (Click for more...) Government health commitments just a ‘pipedream’ 1/17/2020 6:42:31 AM The plans were “ambitions”, and primary care is not being given the time, support and funding it needs. (Click for more...)
Copyright© 2020 West Virginia Society of Health System Pharmacists. All rights reserved.